We have recently reported that inhibition of PAK1 suppressed pancreatic cancer and stimulated the anti-tumour immunity of PC by down regulation of the expression of PD-L1 (a key target of immune checkpoint inhibition [8]) by cancer cells. This evidence concerns the gene PAK1 and pancreatic neoplasm.